First Mercantile Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $126K | Buy |
+208
| New | +$126K | 0.02% | 577 |
|
|
2021
Q1 | – | Sell |
-341
| Closed | -$165K | – | 880 |
|
|
2020
Q4 | $165K | Buy |
+341
| New | +$165K | 0.02% | 508 |
|
|
2020
Q1 | – | Sell |
-370
| Closed | -$139K | – | 889 |
|
|
2019
Q4 | $139K | Buy |
+370
| New | +$139K | 0.02% | 583 |
|
|
2018
Q3 | – | Sell |
-800
| Closed | -$276K | – | 944 |
|
|
2018
Q2 | $276K | Sell |
800
-700
| -47% | -$242K | 0.06% | 405 |
|
|
2018
Q1 | $517K | Hold |
1,500
| – | – | 0.11% | 241 |
|
|
2017
Q4 | $564K | Sell |
1,500
-300
| -17% | -$113K | 0.11% | 229 |
|
|
2017
Q3 | $805K | Hold |
1,800
| – | – | 0.15% | 169 |
|
|
2017
Q2 | $884K | Sell |
1,800
-800
| -31% | -$393K | 0.16% | 147 |
|
|
2017
Q1 | $1.01M | Sell |
2,600
-300
| -10% | -$116K | 0.15% | 168 |
|
|
2016
Q4 | $1.07M | Sell |
2,900
-69
| -2% | -$25.3K | 0.16% | 154 |
|
|
2016
Q3 | $1.19M | Sell |
2,969
-250
| -8% | -$101K | 0.16% | 171 |
|
|
2016
Q2 | $1.12M | Buy |
3,219
+350
| +12% | +$122K | 0.14% | 182 |
|
|
2016
Q1 | $1.03M | Sell |
2,869
-115
| -4% | -$41.4K | 0.13% | 202 |
|
|
2015
Q4 | $1.62M | Buy |
2,984
+584
| +24% | +$317K | 0.17% | 142 |
|
|
2015
Q3 | $1.12M | Hold |
2,400
| – | – | 0.11% | 240 |
|
|
2015
Q2 | $1.22M | Hold |
2,400
| – | – | 0.1% | 254 |
|
|
2015
Q1 | $1.08M | Buy |
+2,400
| New | +$1.08M | 0.09% | 301 |
|
|
2014
Q2 | – | Sell |
-260
| Closed | -$78K | – | 1247 |
|
|
2014
Q1 | $78K | Buy |
+260
| New | +$78K | 0.01% | 947 |
|